Ureteral stent
09980831 ยท 2018-05-29
Assignee
Inventors
Cpc classification
A61M25/0009
HUMAN NECESSITIES
A61M25/002
HUMAN NECESSITIES
A61M27/008
HUMAN NECESSITIES
A61F2/848
HUMAN NECESSITIES
A61F2/0095
HUMAN NECESSITIES
A61L31/06
HUMAN NECESSITIES
A61M2207/00
HUMAN NECESSITIES
A61M25/0102
HUMAN NECESSITIES
A61F2/04
HUMAN NECESSITIES
International classification
A61F2/04
HUMAN NECESSITIES
A61M27/00
HUMAN NECESSITIES
A61L31/06
HUMAN NECESSITIES
A61F2/848
HUMAN NECESSITIES
A61F2/00
HUMAN NECESSITIES
Abstract
A ureteral stent comprises an internal portion, which comprises a first polymer, and an external portion, which comprises a second polymer. The external portion surrounds the internal portion and has a plurality of radial projections that extend along the length of the ureteral stent. The second polymer has a Shore D hardness of 20-40 Shore D. The first polymer has a Shore D hardness that is at least 10 units greater than the Shore D hardness of the second polymer.
Claims
1. A ureteral stent, consisting of: an internal portion, comprising a first polymer, and an external portion surrounding the internal portion and forming 2-10 radial projections that extend along the length of the ureteral stent, comprising a second polymer, wherein the second polymer has a Shore D hardness of 20-40 Shore D, and the first polymer has a Shore D hardness that is at least 10 units greater than the Shore D hardness of the second polymer.
2. The ureteral stent of claim 1, wherein the internal portion defines a lumen.
3. The ureteral stent of claim 1, wherein the internal portion does not define a lumen.
4. The ureteral stent of claim 1, wherein the ureteral stent is not coiled.
5. The ureteral stent of claim 1, wherein the first polymer has a hardness of 35-70 Shore D.
6. The ureteral stent of claim 1, wherein the first polymer and the second polymer consist of thermoplastic elastomers.
7. The ureteral stent of claim 1, wherein the first polymer and the second polymer consist of polyether block amides (PEBAs).
8. The ureteral stent of claim 1, wherein the radial projections are substantially normal to the external portion.
9. The ureteral stent of claim 1, wherein the radial projections are curved.
10. The ureteral stent of claim 1, wherein the radial projections have the shape of one or more lobes extending from the terminal portion of the radial projections.
11. The ureteral stent of claim 1, wherein the ureteral stent is sterile.
12. A coated ureteral stent, comprising: the ureteral stent of claim 1, and a coating on the external portion, wherein the coating is selected from the group consisting of hydrophilic coatings, antibacterial coatings, antimicrobial coatings, and combinations thereof.
13. The ureteral stent of claim 1, wherein the external portion forms 6 radial projections, the first polymer has a hardness of 40 Shore D, the second polymer has a hardness of 25 Shore D, the first polymer and the second polymer consist of polyether block amides, the radial projections are substantially normal to the external portion, and the ureteral stent is sterile.
14. A kit, comprising: a guidewire, and the ureteral stent of claim 1, wherein the guidewire and the ureteral stent are sterile.
15. The kit of claim 14, further comprising a pusher.
16. The kit of claim 14, further comprising a pusher, a container, a lubricant, and printed instructions, wherein the guidewire and the ureteral stent are housed in the container, and the guidewire is pre-threaded through the ureteral stent.
17. A ureteral stent, consisting of: an internal portion, comprising a first polymer, an external portion surrounding the internal portion and forming 2-10 radial projections that extend along the length of the ureteral stent, comprising a second polymer, and a middle portion comprising a third polymer, wherein the second polymer has a Shore D hardness of 20-40 Shore D, and the first polymer has a Shore D hardness that is at least 10 units greater than the Shore D hardness of the second polymer.
18. A coated ureteral stent, comprising: the ureteral stent of claim 17, and a coating on the external portion, wherein the coating is selected from the group consisting of hydrophilic coatings, antibacterial coatings, antimicrobial coatings, and combinations thereof.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The invention can be better understood with reference to the following drawings and description.
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
DETAILED DESCRIPTION
(13) The present invention is a ureteral stent that is significantly more comfortable than existing stents. The ureteral stent has a plurality of radial projections and is composed of at least two polymers, each having a different hardness. The exterior of the ureteral stent is composed of the softer polymer to provide a device that is less irritating to patients, while the interior of the ureteral stent is composed of the harder polymer to provide the rigidity needed for handling and insertion. Patient comfort is also improved by radial projections that minimize contact between the ureteral stent and the ureter. These design features improve the patient experience and produce significant cost savings by reducing the need for medical intervention after the stent has been placed.
(14) In addition to increasing patient comfort, the ureteral stent also provides clinical advantages during stent placement. As compared to the softer polymer, the harder polymer has a lower coefficient of friction with the guidewire used during stent insertion. The reduced coefficient of friction results in improved guidewire tracking and more accurate manipulation of the ureteral stent.
(15)
(16)
(17)
(18) The first polymer and the second polymer each have a different hardness. The first polymer provides the rigidity necessary for handling and insertion, while the second polymer is selected to improve patient comfort since it is the only portion of the ureteral stent that is in direct contact with the ureter. The hardness of the polymers may be determined using a durometer and may be measured in units of Shore D. The first polymer has a Shore D hardness that is at least 10 units greater than the Shore D hardness of the second polymer. Preferably, the first polymer has a hardness of 35-70 Shore D, including 35, 40, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65 and 70 Shore D. Preferably, the second polymer has a hardness of 20-40 Shore D, including 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 and 40 Shore D. The polymers may be thermoplastic elastomers. Preferred thermoplastic elastomers include polyurethanes and polyether block amides, such as PEBAX (Arkema, France).
(19) The optional lumen is the internal portion defined by the material of the ureteral stent.
(20)
(21) The radial projections may extend from the external portion of the ureteral stent, or may form the external portion of the ureteral stent. Preferably, the ureteral stent includes 2, 3, 4, 5, 6, 7, 8, 9 or 10 radial projections. When the ureteral stent has been placed in a ureter, the radial projections exert a slight outward pressure on the inner surface of the ureter. This pressure helps keep the ureteral stent in place and reduces the need to coil the ends of the ureteral stent.
(22) The radial projections may have a variety of shapes and configurations.
(23) The radial projections define an equivalent number of external channels, as shown in
(24) The ureteral stent may be composed of more than two polymers.
(25) The ureteral stent may optionally be radiopaque. A radiopaque ureteral stent is capable of having its placement confirmed by X-ray or fluoroscopy. The polymers that compose the ureteral stent may be radiopaque, or the stent may include radiopaque markers. For example, a ureteral stent may include radiopaque markers at regular intervals along the length of the ureteral stent, such as every 5 cm.
(26) The ureteral stent may optionally include a coating on the external portion of the ureteral stent. A hydrophilic coating may be used to improve patient comfort or to facilitate insertion. An antibacterial or antimicrobial coating, such as heparin, may be used to reduce infection or encrustation. The ureteral stent may be coated with a single substance, or with a combination of multiple substances.
(27) The ureteral stent may optionally include removal components attached to the bladder end of the ureteral stent.
(28) The ureteral stent may be provided in a variety of sizes to accommodate the range of ureter lengths that are encountered in adult and pediatric patients. The length of the ureteral stent is sized so that it travels the full length of the ureter and extends into the kidney and the bladder. Suitable lengths for a ureteral stent range from 10-40 cm, preferably 16-28 cm. The outer diameter of the ureteral stent is sized to match the diameter of a typical adult or pediatric ureter. The outer diameter of the ureteral stent may be determined by measuring the terminal portions of two opposite radial projections, or may be determined by measuring the distance from the center of the ureteral stent to the terminal portion of a radial projection and doubling this value. The outer diameter of a ureteral stent may be expressed according to the French catheter scale (abbreviated as Fr, Ga, Fg, FR or F), but may also be measured in units of length such as inches or millimeters. Suitable outer diameters for a ureteral stent range from 3-9 Fr (1-3 mm, or 0.039-0.118 in).
(29) The ureteral stent may be produced by any suitable polymer manufacturing process. The manufacturing process must be capable of creating a monolithic device composed of multiple polymers with different degrees of hardness. The manufacturing process must also be capable of producing a device with the precise dimensions necessary for use in a ureter. Preferably, the ureteral stent is formed by co-extrusion.
(30)
(31) The kit may optionally include a lubricant for inserting the ureteral stent. The lubricant may be supplied in a squeezable packet or tube. Alternatively, the ureteral stent may be supplied pre-lubricated. A pre-lubricated ureteral stent may be provided in a sealed package within the kit.
(32) The kit may optionally include instructions for use. The instructions may be provided as printed instructions or in electronic format, such as on a universal serial bus (USB) drive, on a secure digital (SD) card, or hosted over the internet and accessible through a quick response (QR) code.
(33) The kit may optionally include a container for housing the kit ingredients. The container protects the guidewire, ureteral stent and any other components from damage. The container may be formed of a rigid, durable material such as plastic.
(34) Kits may be provided that contain different sized ureteral stents for different intended patients. For example, a kit for use in adult patients may contain a 26 cm ureteral stent with a 9 French outer diameter. Similarly, a kit for use in pediatric patients may contain a 16 cm ureteral stent with a 3 French outer diameter.
(35) The ureteral stent may be inserted into a ureter via the urethra (retrograde stenting) or via an incision through the skin and kidney (antegrade stenting). Retrograde stenting is the preferred insertion method because it is less invasive than antegrade stenting. However, antegrade stenting is appropriate in certain situations, such as when performed in conjunction with a percutaneous nephrolithotomy or when the urethra is not accessible.
(36) In addition to use in humans, the ureteral stent may also be used in animals. An appropriately-sized ureteral stent may be used to maintain the patency of a ureter of an animal in need of treatment. The ureteral stent may be used to treat companion animals, such as dogs and cats, or livestock, such as horses.
EXAMPLES
Example 1
(37) A ureteral stent was formed by co-extruding PEBAX grade 2533 (Arkema, France) and PEBAX grade 4033 (Arkema, France). The PEBAX grade 2533 had a hardness of 25 Shore D and formed the external portion of the ureteral stent. The PEBAX grade 4033 had a hardness of 40 Shore D and formed the internal portion of the ureteral stent.
Example 2 (Prophetic)
(38) A 50 year old female goes to a urologist complaining of sharp pains in her lower back and difficulty urinating. The urologist performs an X-ray and determines that the patient has a kidney stone in her left kidney. To avoid a blockage of the patient's left ureter, the urologist recommends the insertion of a ureteral stent. The urologist elects retrograde insertion of the ureteral stent. The patient is placed under general anesthesia. A guidewire is inserted through the patient's urethra, bladder, left ureter and into her left kidney with the aid of a cystoscope. A portion of the guidewire remains outside of the patient's body. A radiopaque, dual-hardness ureteral stent with six radial projections, a closed lumen and a small rare earth magnet attached to the bladder end is threaded over the portion of the guidewire extending outside of the patient's body. A pusher is then threaded over the external portion of the guidewire and used to advance the ureteral stent along the guidewire and into the ureter. The placement of the ureteral stent is confirmed by fluoroscopy. The pusher and the guidewire are then removed. After the procedure the patient is able to pass urine through the ureter. The ureteral stent is non-irritating and the patient does not require medical intervention to address pain. The ureteral stent is removed using a catheter with a matching rare earth magnet after the kidney stone has been broken up and passed.
REFERENCES
(39) 1. Urinary system, available online at en.wikipedia.org/wiki/Urinary_system (Jul. 2, 2015). 2. Ureter, available online at en.wikipedia.org/wiki/Ureter (Jun. 24, 2015). 3. Ureteric stent, available online at en.wikipedia.org/wiki/Ureteric_stent (Jul. 1, 2015). 4. Towers Peripheral Ureteral Stent Set, Cook Medical, available online at www.cookmedical.com/products/uro_towerswebds/ (2015). 5. Singh, I., Indwelling JJ ureteral stentsa current perspective and review of literature, Indian Journal of Surgery, Vol. 65, No. 5, pp. 405-412 (September-October 2003), available online at www.bioline.org.br/request?is03080. 6. PEBAX Polyether Block Amides, Arkema, available online at www.PEBAX.com/export/sites/PEBAX/content/medias/downloads/literature/PEBAX-product-range-brochure.pdf (Downloaded on Jul. 17, 2015).